DLACX
Price
$17.50
Change
-$0.28 (-1.57%)
Updated
Sep 6 closing price
GFACX
Price
$61.91
Change
-$1.33 (-2.10%)
Updated
Sep 6 closing price
Ad is loading...

DLACX vs GFACX

Header iconDLACX vs GFACX Comparison
Open Charts DLACX vs GFACXBanner chart's image
BNY Mellon Large Cap Equity Y
Price$17.50
Change-$0.28 (-1.57%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$61.91
Change-$1.33 (-2.10%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DLACX vs GFACX Comparison Chart
Loading...
VS
DLACX vs. GFACX commentary
Sep 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLACX is a Buy and GFACX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 270B vs. DLACX (269M). DLACX pays higher dividends than GFACX: DLACX (1.00) vs GFACX (0.00). DLACX was incepted earlier than GFACX: DLACX (9 years) vs GFACX (24 years). DLACX is a more actively managed with annual turnover of: 70.46 vs. GFACX (31.00). GFACX has a lower initial minimum investment than DLACX: GFACX (250) vs DLACX (1000000). GFACX annual gain was more profitable for investors over the last year : 16.44 vs. DLACX (-13.12). GFACX return over 5 years is better than : 38.56 vs. DLACX (-12.72).
DLACXGFACXDLACX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years24 years-
Gain YTD3.44514.98223%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets269M270B0%
Annual Yield % from dividends1.000.00-
Returns for 1 year-13.1216.44-80%
Returns for 3 years-42.57-11.08384%
Returns for 5 years-12.7238.56-33%
Returns for 10 yearsN/A42.46-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KW11.040.03
+0.27%
Kennedy-Wilson Holdings
CTVA55.11-0.39
-0.70%
Corteva
FIVN29.58-0.24
-0.80%
Five9
VEV0.14N/A
-1.68%
Vicinity Motor Corp
ADAP1.11-0.05
-4.31%
Adaptimmune Therapeutics plc